EAN 2024 | Neuromuscular disorder treatment updates at EAN 2024

Nicolas Dubuisson, MD, Cliniques universitaires Saint-Luc, Brussels, Belgium, highlights the increased availability of treatments for neuromuscular diseases. Myasthenia gravis and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are two diseases where treatments have evolved the most. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.